Purdue Pharma Foquest Capsule recall in Canada: potency issue
In plain language
This recall involves Foquest 35 mg, 45 mg, 70 mg, and 85 mg capsules sold in Canada. It's being recalled because the capsules showed out-of-specification potency during shelf-life testing. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot numbers provided in the official notice.
- Contact your healthcare professional for advice.
- Return the product as instructed by Purdue Pharma Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Foquest 35 mg capsule
Lot: 135568
Foquest 45 mg capsule
Lot: 135569
Foquest 70 mg capsule
Lot: 134046
Foquest 85 mg capsule
Lot: 135571
Why this matters
Product safety issue due to potency
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 134046, 135568, 135569, 135571
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product safety issue due to potency
What should consumers do?
Stop using the product immediately. Check the lot numbers provided in the official notice. Contact your healthcare professional for advice. Return the product as instructed by Purdue Pharma Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product safety issue due to potency
When was this product recalled?
This product was recalled on July 25, 2019.
Is the Foquest brand affected by this recall?
Yes, Foquest products are affected by this recall. This recall involves Foquest 35 mg, 45 mg, 70 mg, and 85 mg capsules sold in Canada. It's being recalled because the capsules showed out-of-specification potency during shelf-life testing. Stop using the product and follow the return steps in the official notice.